Evidence map›Paper›PMID 36894702›Full record

ArticleNature chemistry2023

Unusual peptide-binding proteins guide pyrroloindoline alkaloid formation in crocagin biosynthesis.

Sebastian Adam, Dazhong Zheng, Andreas Klein, Carsten Volz, William Mullen, Sally L Shirran, Brian O Smith, Olga V Kalinina, Rolf Müller, Jesko Koehnke

Open access · hybridAbstract read
In one paragraph

Article in Nature chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Sebastian AdamWorkgroup Structural Biology of Biosynthetic Enzymes, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University, Saarbrücken, Germany.
Dazhong ZhengSchool of Chemistry, University of Glasgow, Glasgow, UK.ORCID http://orcid.org/0000-0001-8639-5864
Andreas KleinWorkgroup Structural Biology of Biosynthetic Enzymes, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University, Saarbrücken, Germany.ORCID http://orcid.org/0000-0002-4808-4691
Carsten VolzDepartment of Microbial Natural Products, HIPS; HZI; Department of Pharmacy, Saarland University, Saarbrücken, Germany.ORCID http://orcid.org/0000-0001-7094-5294
William MullenInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Sally L ShirranBiomedical Sciences Research Complex, University of St Andrews, St Andrews, UK.
Brian O SmithSchool of Molecular Biosciences, University of Glasgow, Glasgow, UK.ORCID http://orcid.org/0000-0003-3363-4168
Olga V KalininaDrug Bioinformatics Group, HIPS, HZI, Saarland University, Saarbrücken, Germany.ORCID http://orcid.org/0000-0002-9445-477X
Rolf MüllerDepartment of Microbial Natural Products, HIPS; HZI; Department of Pharmacy, Saarland University, Saarbrücken, Germany.ORCID http://orcid.org/0000-0002-1042-5665
Jesko KoehnkeWorkgroup Structural Biology of Biosynthetic Enzymes, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University, Saarbrücken, Germany. jesko.koehnke@glasgow.ac.uk.ORCID http://orcid.org/0000-0002-7153-1365
Helmholtz Centre for Infection Research · DEUniversity of Glasgow · GBGerman Center for Infection Research · DEHochschule für Technik und Wirtschaft des Saarlandes · DESaarland University · DEUniversity of St Andrews · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ribosomally synthesized and post-translationally modified peptide natural products have provided many highly unusual scaffolds. This includes the intriguing alkaloids crocagins, which possess a tetracyclic core structure and whose biosynthesis has remained enigmatic. Here we use in vitro experiments to demonstrate that three proteins, CgnB, CgnC and CgnE, are sufficient for the production of the hallmark tetracyclic crocagin core from the precursor peptide CgnA. The crystal structures of the homologues CgnB and CgnE reveal them to be the founding members of a peptide-binding protein family and allow us to rationalize their distinct functions. We further show that the hydrolase CgnD liberates the crocagin core scaffold, which is subsequently N-methylated by CgnL. These insights allow us to propose a biosynthetic scheme for crocagins. Bioinformatic analyses based on these data led to the discovery of related biosynthetic pathways that may provide access to a structurally diverse family of peptide-derived pyrroloindoline alkaloids.

Indexed as

ProteinsAlkaloidsBiocatalysisModels, MolecularPeptides, CyclicProtein BindingProtein MultimerizationProtein Structure, QuaternaryProtein Structure, TertiaryPyrrolesZincAlkaloidsPeptides, CyclicProteinsPyrrolespyrroloindolizineZinc

Identifiers

PMID36894702
PMCPMC10070186
OpenAlexW4323659999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.